Duration of High-Dose Aspirin Therapy does not Affect Long-Term Coronary Artery Outcomes in Kawasaki Disease

BACKGROUND: High-dose aspirin (HDA) is used with intravenous immunoglobulin (IVIg) in Kawasaki Disease (KD). Practice regarding HDA varies, and it is unclear whether HDA duration affects long-term course. METHODS: We retrospectively studied KD patients at our hospital over 10 years. Patients were ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Migally, Karl, Braunlin, Elizabeth A., Zhang, Lei, Binstadt, Bryce A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6019159/
https://www.ncbi.nlm.nih.gov/pubmed/29554081
http://dx.doi.org/10.1038/pr.2018.44

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6019159/
https://www.ncbi.nlm.nih.gov/pubmed/29554081
http://dx.doi.org/10.1038/pr.2018.44

Ejemplares similares